Delayed second dose and third doses of the Oxford-AstraZeneca vaccine lead to heightened immune response
Research on the ChAdOx1 nCoV-19, also known as the Oxford-AstraZeneca vaccine, indicates that a long interval between first and second doses does not compromise the immune response after a late second dose. Additionally, a third dose of the vaccine continues to boost antibodies against SARS-CoV-2. The results were released in a preprint today. Delayed second dose The researchers